N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease

Journal of the Neurological Sciences

Volumn 182, Issue 2, 2001, Pages 151-159

  Sze, Chun I ^a   Bi, Hong ^a   Kleinschmidt DeMasters, B K ^a   Filley, Christopher M ^a,b   Martin, Lee J ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Entorhinal cortex; Excitotoxicity; Glutamate; Hippocampus; Long term potentiation

Indexed keywords

IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTORHINAL CORTEX; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0035188745     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00467-6     Document Type: Article

References (39)

1. A synaptic model of memory: Long-term potentiation in the hippocampus
2. The toxic effect of sodium L-glutamate on the inner layers of the retina
3. Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study
4. Kainic acid: A powerful neurotoxic analogue of glutamate
5. Glutamate neurotoxicity and diseases of the nervous system
6. Excitotoxic cell death
7. Role of excitotoxins in heredito-degenerative neurological diseases
8. Excitatory transmitter neurotoxicity
9. A secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosome by a cyclic GMP-mediated mechanism
10. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
11. Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: Relation to Alzheimer's disease
12. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases
13. 3H]glutamate binding
14. Density and distribution of NMDA receptor in the human hippocampal in Alzheiemr's disease
15. 3H]TCP binding sites in Alzheimer's disease
16. Genetic enhancement of learning and memory in mice
17. Tyrosine phosphorylation in a model of ischemia using the rat hippocampal slice: Specific long-term decrease in the tyrosine phosphorylation of the postsynaptic glycoprotein PSD-GP180
18. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease
19. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brain
20. Alzheimer's disease: A correlational analysis of the Blessed Information-Memory-Concentration test and the Mini-Mental State examination
21. Neuropathological staging of Alzheimer-related changes
22. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease
23. N-Methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies
24. Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein
25. Altered levels of microtubule proteins in brains of Alzheimer's disease patients
26. Perforant pathway changes and the memory impairment of Alzheimer's disease
27. Protein phosphotyrosine in mouse brain: Developmental changes and regulation by epidermal growth factor, type I insulin-like growth factor, and insulin
28. Glutamate receptor modulation by protein phosphorylation
29. Life and death of neurons in the aging brain
30. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer's disease
31. Expression of endogenous NMDAR1 transcripts without receptor protein suggests post-transcriptional control in PC-12 cells
32. Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation
33. Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies
34. The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease
35. Molecular diversity of glutamate receptors and their physiological functions
36. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments
37. CaMKII-dependent phosphorylation of NR2A and NR2B is decreased in animals characterized by hippocampal damage and impaired LTP
38. Role of NMDA receptors in memory
39. The role of protein kinase C in long-term potentiation: A testable model